Global X HealthTech ETF HEAL
Set alert
30.67 USD -0.18 -0.60%
As of Nov 3, 9:44 AM ET
30.64 Day range 30.67
23.00 52-week range 32.15
- YTD
- +4.96%
- 1 year
- -3.16%
- Open
- 30.64
- Prev close
- 30.86
- Mkt cap
- 35.03M
- Vol
- 76.08K
- Avg vol
- 9.62K
- EPS
- 1.08
- P/E
- 28.45
- Div yield
- 0.00%
More statistics
- Low
- 30.64
- High
- 30.67
3M chart
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
Newest 20 of 21.
News
- Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch
- Restart Life Sciences Launches HC Protein+ Products Online and Advances AI-Driven E-Commerce Strategy
- Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience
- Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth
- Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
- Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
- Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
- Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
- Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
- Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY
Your note
Sign in to keep a note on HEAL — it syncs with the Stock Master app.